Effects of estrogen on stress responses in women.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 10566690)

Published in J Clin Endocrinol Metab on November 01, 1999

Authors

P A Komesaroff, K Sudhir, M D Esler

Articles by these authors

Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med (1991) 2.44

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation (1986) 2.38

Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol (1995) 2.15

Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension (1996) 1.93

Human ageing and the sympathoadrenal system. J Physiol (2000) 1.93

Cardiac sympathetic nerve function in congestive heart failure. Circulation (1996) 1.84

Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J (2001) 1.75

Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab (2001) 1.71

Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry (1998) 1.70

Ethics and clinical medicine. Aust N Z J Med (1993) 1.66

Effect of sunlight and season on serotonin turnover in the brain. Lancet (2002) 1.63

Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure. Cardiovasc Res (1999) 1.62

Levels of anxiety in colonic disorders. N Engl J Med (1973) 1.60

Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol (1993) 1.55

Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol (1996) 1.54

Panic disorder: coronary spasm as a basis for cardiac risk? Med J Aust (1998) 1.51

Effect of changing levels of physical activity on blood-pressure and haemodynamics in essential hypertension. Lancet (1986) 1.50

Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol (2001) 1.44

Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation (1994) 1.43

Communication deficiencies in research and monitoring by ethics committees. Intern Med J (2006) 1.42

The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension. J Hypertens (2000) 1.42

Use of complementary medicines: scientific and ethical issues. Med J Aust (1998) 1.41

Between a rock and a hard place: exploring the conflict between respecting the privacy of patients and informing their carers. Intern Med J (2009) 1.39

Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. J Lab Clin Med (1991) 1.39

Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest (1995) 1.32

Radiofrequency catheter ablation guided by intracardiac echocardiography. Circulation (1994) 1.30

Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation (1996) 1.30

Neural mechanisms in human obesity-related hypertension. J Hypertens (1999) 1.30

Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension (1997) 1.28

Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab (1999) 1.21

Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness. Br Heart J (1973) 1.18

Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation (1993) 1.16

Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res (2000) 1.14

Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol (1994) 1.13

Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension (1991) 1.11

Noradrenaline release and sympathetic nervous system activity. J Hypertens (1985) 1.10

Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric (2001) 1.04

Exercise and aging: autonomic control of the circulation. Med Sci Sports Exerc (1994) 1.02

Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans. Am J Physiol (1998) 1.01

Acute effects of continuous positive airway pressure on cardiac sympathetic tone in congestive heart failure. Circulation (2001) 1.01

Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet (1997) 1.00

Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol (1995) 1.00

Disposition of endogenous adrenaline compared to noradrenaline released by cardiac sympathetic nerves in the anaesthetized dog. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.99

In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats. J Am Coll Cardiol (1998) 0.98

Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.98

Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol (1997) 0.96

Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins. J Am Coll Cardiol (1996) 0.96

Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Circulation (1995) 0.95

Cell adhesion molecules as pharmaceutical target in atherosclerosis. Mini Rev Med Chem (2012) 0.94

Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure. J Am Coll Cardiol (2001) 0.94

Regional sympathetic nervous activation after a large meal in humans. Clin Sci (Lond) (1995) 0.94

Clinical review 110: Cardiovascular actions of estrogens in men. J Clin Endocrinol Metab (1999) 0.93

Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine. Circulation (1992) 0.93

Reactivity of endothelin-1 on human and canine large veins compared with large arteries in vitro. Eur J Pharmacol (1989) 0.92

Regional epinephrine kinetics in human heart failure: evidence for extra-adrenal, nonneural release. Am J Physiol (1995) 0.92

Total norepinephrine spillover, muscle sympathetic nerve activity and heart-rate spectral analysis in a patient with dopamine beta-hydroxylase deficiency. J Auton Nerv Syst (1995) 0.92

Time-course of the antihypertensive and autonomic effects of regular endurance exercise in human subjects. J Hypertens (1990) 0.91

Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis. Gastroenterology (1993) 0.91

Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion. J Am Coll Cardiol (2000) 0.91

Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens (1993) 0.90

Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension (2000) 0.89

Relationship of age and blood pressure to baroreflex sensitivity and arterial compliance in man. Clin Sci Mol Med Suppl (1976) 0.89

Blunted norepinephrine responsiveness to changing energy states in obese subjects. Metabolism (1985) 0.89

Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation. J Auton Nerv Syst (1995) 0.89

Altered cardiac responsiveness and regulation in the normal cardiac output type of borderlind hlpertension. Circ Res (1975) 0.88

Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog. Circulation (1991) 0.88

Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension (1992) 0.88

Measurement of human sympathetic nervous responses to stressors by microneurography. J Auton Nerv Syst (1994) 0.88

Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. Am J Physiol (1991) 0.87

Increased norepinephrine spillover into the jugular veins in essential hypertension. Hypertension (1992) 0.87

Sympathetic responsiveness to head-up tilt in essential hypertension. Clin Sci (1973) 0.87

Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries. Am J Physiol (1999) 0.86

Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. Acta Physiol Scand (1998) 0.86

Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. J Am Coll Cardiol (1997) 0.86

Regional 5-hydroxyindoleacetic acid production in humans. Life Sci (1995) 0.85

Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension. J Hypertens (2001) 0.85

Cerebral noradrenaline spillover and its relation to muscle sympathetic nervous activity in healthy human subjects. J Auton Nerv Syst (1997) 0.85

Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure. Hypertension (1992) 0.85

Relation of renin status to neurogenic vascular resistance in borderline hypertension. Am J Cardiol (1975) 0.85

Sympatholytic action of intravenous amiodarone in the rat heart. Circulation (1995) 0.84

Altered venous responses to vasoconstrictor agonists and nerve stimulation in human primary hypertension. J Hypertens (1990) 0.84

Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S-nitrosylation. Br J Pharmacol (2000) 0.84

Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function. Hypertension (1989) 0.84

Depression of efferent parasympathetic control of heart rate in rats with myocardial infarction: effect of losartan. J Cardiovasc Pharmacol (1998) 0.84

High catecholamine essential hypertension: clinical and physiological characteristics. Aust N Z J Med (1973) 0.84

Norepinephrine spillover to plasma during steady-state supine bicycle exercise. Comparison of patients with congestive heart failure and normal subjects. Circulation (1988) 0.84

Influence of variation in dietary sodium intake on biochemical indices of sympathetic activity in normal man. Clin Exp Pharmacol Physiol (1984) 0.84

Tamoxifen is an acute, estrogen-like, coronary vasodilator of porcine coronary arteries in vitro. J Cardiovasc Pharmacol (2001) 0.84

Complementary medicine use among people living with HIV/AIDS in Victoria, Australia: practices, attitudes and perceptions. Int J STD AIDS (2007) 0.83

Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension. Am J Cardiol (1973) 0.83

Combating the obesity epidemic: cultural problems demand cultural solutions. Intern Med J (2007) 0.83

Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Hypertension (1997) 0.83

Rapid potentiation of endothelium-dependent vasodilation by estradiol in postmenopausal women is mediated via cyclooxygenase 2. J Clin Endocrinol Metab (2002) 0.82

In vitro quantification of radiofrequency ablation lesion size using intracardiac echocardiography in dogs. Am J Cardiol (1996) 0.82

Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clin Auton Res (1991) 0.82

Endothelin is blood vessel selective: studies on a variety of human and dog vessels in vitro and on regional blood flow in the conscious rabbit. Clin Exp Pharmacol Physiol (1989) 0.82